Literature DB >> 11380312

Review article: the genetics of inflammatory bowel disease.

T Ahmad1, J Satsangi, D McGovern, M Bunce, D P Jewell.   

Abstract

Recent epidemiological, clinical and molecular studies have provided strong evidence that inherited predisposition is important in the pathogenesis of chronic inflammatory bowel diseases. The model most consistent with the epidemiological data suggests that Crohn's disease and ulcerative colitis are related polygenic diseases, sharing some but not all susceptibility genes. Investigators throughout the world have applied the complementary techniques of genome-wide scanning and candidate gene analysis. Four areas of linkage have been widely replicated on chromosomes 16 (IBD1), 12 (IBD2), 6 (IBD3-the HLA region), and most recently on chromosome 14. Fine mapping of these regions is underway. Of the 'positional' candidate genes, most attention has centred on the genes of the major histocompatibility complex. Genes within this region may determine disease susceptibility, behaviour, complications and response to therapy. Hope continues that studies of inflammatory bowel disease genetics will provide fresh insight into disease pathogenesis and soon deliver clinical applications.

Entities:  

Mesh:

Year:  2001        PMID: 11380312     DOI: 10.1046/j.1365-2036.2001.00981.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  35 in total

1.  Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families.

Authors:  Turgut Tukel; Adel Shalata; Daniel Present; Daniel Rachmilewitz; Lloyd Mayer; Deniera Grant; Neil Risch; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2004-03-05       Impact factor: 11.025

Review 2.  Genetics of liver disease: immunogenetics and disease pathogenesis.

Authors:  P T Donaldson
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 3.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 4.  Application of computational methods in genetic study of inflammatory bowel disease.

Authors:  Jin Li; Zhi Wei; Hakon Hakonarson
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 5.  Probiotics and prebiotics in chronic inflammatory bowel diseases.

Authors:  Julia B Ewaschuk; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 6.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

7.  CARD15/NOD2 in a Tunisian population with Crohn's disease.

Authors:  Lilia Zouiten-Mekki; Habib Zaouali; Jalel Boubaker; Sami Karoui; Monia Fekih; Samira Matri; Sami Hamzaoui; Azza Filali; Habiba Chaabouni; Jean Pierre Hugot
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

8.  Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia.

Authors:  Imen Sfar; Walid Ben Aleya; Leila Mouelhi; Houda Aouadi; Thouraya Ben Rhomdhane; Mouna Makhlouf; Salwa Ayed-Jendoubi; Houda Gargaoui; Taoufik Najjar; Taieb Ben Abdallah; Khaled Ayed; Yousr Gorgi
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

9.  Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD.

Authors:  Walid Ben Aleya; Imen Sfar; Leila Mouelhi; Houda Aouadi; Mouna Makhlouf; Salwa Ayed-Jendoubi; Samira Matri; Azza Filali; Taoufik Najjar; Taeib Ben Abdallah; Khaled Ayed; Yousr Gorgi
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

10.  Manometric study in ulcerative colitis patients with modified ileal pouch--anal anastomosis.

Authors:  Georgi Kobakov; Daniel Kostov; Temelko Temelkov
Journal:  Int J Colorectal Dis       Date:  2006-04-01       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.